Critically ill COVID-19 patients exhibit significantly higher concentrations of interleukins, TNF-α, and immune attractant proteins (protein 1 and protein 1A) compared to mildly infected cases [[18], [22], [23]]. This evidence concerns the gene TNF and COVID-19.